What to Watch in the Day Ahead - Friday, April 26

Reuters04-26

(The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at

. Thomson One users can register at RT/DAY/US. All times in ET/GMT)

A report from the Commerce Department's Bureau of Economic Analysis is likely to show the personal consumption expenditures (PCE) price index likely rose 0.3% in March after a similar rise in the previous month. In the 12 months through March, PCE likely increased 2.6% after advancing 2.5% in February. Excluding the volatile food and energy components, the PCE price index is expected to rise 0.3% in March, following a similar rise in the month before. The so-called core PCE is expected to gain 2.7% on a year-on-year basis. Meanwhile, consumer spending is expected to have eased with a rise of 0.6% in March after jumping 0.8% in the previous month. Personal income likely grew 0.5% in March, following a 0.3% gain in the previous month. Separately, the University of Michigan's final reading on the overall index of consumer sentiment likely came in at 77.9 in April, unchanged from the previous month.

Oil major Exxon is expected to report first-quarter earnings per share of $2.16 compared with $2.79 a year ago on weaker natural gas prices, higher maintenance costs and derivatives, according to data from financial firm LSEG.

Chevron is expected to report lower first-quarter profits than last year due to weaker oil and gas prices and lower production. Investors will look for a full-year outlook and an update on Hess's acquisition.

Also, AbbVie is scheduled to report its first-quarter earnings. Investor focus is expected to be on the erosion of Humira sales and the growth of its newer immunology drugs, Skyrizi and Rinvoq.

Colgate-Palmolive is expected to post a rise in first-quarter revenue, helped by steady demand for its products including oral care and pet nutrition. Investors will look for comments on pricing actions, demand, impact of increasing competition and annual forecasts.

HCA Healthcare is set to report its first-quarter results before markets open. The focus will be on changes to its annual forecast and comments by the largest U.S. for-profit hospital operator on patient admissions and demand for medical procedures.

Phillips 66 is likely to post a profit decline due to weaker margins; however, tight supplies could boost its margins. Investors will look for any commentary on demand and refining operations.

Charter Communications is expected to post a rise in revenue in the first quarter as it sees steady subscriber growth from its rural expansion plans.

Aon will report higher first-quarter results, helped by the company's growing reliance on its reinsurance products and services.

Asset manager T Rowe Price is scheduled to report its first-quarter earnings. Thanks to a rebound in markets, analysts expect its profit to grow.

Software firm Roper Technologies is expected to report a rise in first-quarter revenue helped by strong IT spending by clients.

In Latin America, Brazil's IPCA-15 consumer price index for the first half of April likely rose 0.29%, following a 0.36% gain in the previous period. Annually, the index probably increased 3.86%. Separately, Mexico's national statistics agency is likely to show a surplus in trade at $700 million for the month of March, after posting a deficit of $585 million in the previous month. Meanwhile, Mexico's headline unadjusted unemployment rate is expected at 2.4% in March.

(Compiled by Shreya Sabharwal in Bengaluru; Editing by Ravi Prakash Kumar)

((Shreya.Sabharwal@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment